| Bioactivity | Sergliflozin-A is a compound used to inhibit type 2 diabetes. It can inhibit glucose transporters in the kidney, competitively inhibit hSGLT1 and hSGLT2, and mutations at different sites have different effects on its inhibitory effect. |
| CAS | 360775-96-8 |
| Formula | C20H24O7 |
| Molar Mass | 376.40 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Inhibitor binding in the human renal low- and high-affinity Na+/glucose cotransporters |
Sergliflozin-A
CAS: 360775-96-8 F: C20H24O7 W: 376.40
Sergliflozin-A is a compound used to inhibit type 2 diabetes. It can inhibit glucose transporters in the kidney, competi
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.